AKT1 and neoplasm: Due to its ability to bind multiple receptors, CCL5 has been linked to multiple pathways that mediate tumor progression, including the JAK2/STAT3, NF-κB, TGFβ, PI3K/Akt, HIF-α, and Ras-ERK-MEK pathways [39].